Rempex Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REMPEX, and when can generic versions of REMPEX drugs launch?
REMPEX has two approved drugs.
There are nine US patents protecting REMPEX drugs.
There are eighty-nine patent family members on REMPEX drugs in thirty-two countries and thirty supplementary protection certificates in fourteen countries.
Drugs and US Patents for Rempex
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 10,183,034 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 9,694,025 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | MINOCIN | minocycline hydrochloride | INJECTABLE;INJECTION | 050444-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 9,278,105 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 11,376,237 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 8,680,136 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 11,007,206 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rempex Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hong Kong | 1180586 | ⤷ Try a Trial |
Japan | 2020002178 | ⤷ Try a Trial |
European Patent Office | 3135289 | ⤷ Try a Trial |
Mexico | 2012012993 | ⤷ Try a Trial |
Australia | 2011252919 | ⤷ Try a Trial |
Hungary | S1900018 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rempex Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2603514 | 2019014 | Norway | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF, AND MEROPENEM, AND/OR A SALT AND/OR HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE; REG. NO/DATE: EU/1/18/1334/001 20181122 |
2603514 | C02603514/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67797 01.07.2021 |
3412676 | PA2020519,C3412676 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120 |
3412676 | PA2020521 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VABORBAKTAMAS IR (ARBA) JO DRUSKA, IR (ARBA) JO HIDRATAS; REGISTRATION NO/DATE: EU/1/18/1334 20181120 |
3412676 | C20200017 00315 | Estonia | ⤷ Try a Trial | PRODUCT NAME: MEROPENEEM/VABORBAKTAAM;REG NO/DATE: EU/1/18/1334 22.11.2018 |
2603514 | 2019C/515 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.